Careplus Group Berhad, an investment holding company, engages in the manufacture, processing, and trade of gloves in South America, North America, Europe, the Middle East, South Africa, Japan, China, Malaysia, India, and Australia. More Details
Flawless balance sheet and fair value.
Share Price & News
How has Careplus Group Berhad's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CAREPLS is more volatile than 75% of MY stocks over the past 3 months, typically moving +/- 12% a week.
Volatility Over Time: CAREPLS's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of MY stocks.
7 Day Return
MY Medical Equipment
1 Year Return
MY Medical Equipment
Return vs Industry: CAREPLS exceeded the MY Medical Equipment industry which returned -60.3% over the past year.
Return vs Market: CAREPLS underperformed the MY Market which returned -0.7% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Careplus Group Berhad's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall StDid You Participate In Any Of Careplus Group Berhad's (KLSE:CAREPLS) Incredible 806% Return?
1 month ago | Simply Wall StWhat Kind Of Shareholders Hold The Majority In Careplus Group Berhad's (KLSE:CAREPLS) Shares?
2 months ago | Simply Wall StDoes Careplus Group Berhad (KLSE:CAREPLS) Have A Healthy Balance Sheet?
Is Careplus Group Berhad undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: CAREPLS (MYR1.74) is trading below our estimate of fair value (MYR67.65)
Significantly Below Fair Value: CAREPLS is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: CAREPLS's PE Ratio (3.8x) is in line with the MY Medical Equipment industry average.
PE vs Market: CAREPLS is good value based on its PE Ratio (3.8x) compared to the MY market (17.1x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate CAREPLS's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: CAREPLS's PB Ratio (2.6x) is in line with the MY Medical Equipment industry average.
How is Careplus Group Berhad forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Careplus Group Berhad has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Careplus Group Berhad performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CAREPLS has a high level of non-cash earnings.
Growing Profit Margin: CAREPLS became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: CAREPLS's earnings have grown significantly by 88.2% per year over the past 5 years.
Accelerating Growth: CAREPLS has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: CAREPLS has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (41.4%).
Return on Equity
High ROE: CAREPLS's Return on Equity (65.3%) is considered outstanding.
How is Careplus Group Berhad's financial position?
Financial Position Analysis
Short Term Liabilities: CAREPLS's short term assets (MYR337.4M) exceed its short term liabilities (MYR217.9M).
Long Term Liabilities: CAREPLS's short term assets (MYR337.4M) exceed its long term liabilities (MYR21.5M).
Debt to Equity History and Analysis
Debt Level: CAREPLS's debt to equity ratio (5.6%) is considered satisfactory.
Reducing Debt: CAREPLS's debt to equity ratio has reduced from 74.4% to 5.6% over the past 5 years.
Debt Coverage: CAREPLS's debt is well covered by operating cash flow (1208.3%).
Interest Coverage: CAREPLS's interest payments on its debt are well covered by EBIT (102.7x coverage).
What is Careplus Group Berhad current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: CAREPLS's dividend (2.3%) is higher than the bottom 25% of dividend payers in the MY market (1.49%).
High Dividend: CAREPLS's dividend (2.3%) is low compared to the top 25% of dividend payers in the MY market (4.17%).
Stability and Growth of Payments
Stable Dividend: CAREPLS has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: CAREPLS's dividend payments have increased, but the company has only paid a dividend for 8 years.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (4.4%), CAREPLS's dividend payments are thoroughly covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Kwee Lim (58 yo)
Mr. Kwee Shyan Lim serves as the Chief Executive Officer at Careplus Group Berhad and has been its Executive Director since March 30, 2010. Mr. Lim joined PPG in 1988 as a Production Executive and was subs...
CEO Compensation Analysis
Compensation vs Market: Insufficient data to establish whether Kwee's total compensation is reasonable compared to companies of similar size in the MY market.
Compensation vs Earnings: Kwee's compensation has been consistent with company performance over the past year.
Experienced Management: CAREPLS's management team is seasoned and experienced (11 years average tenure).
Experienced Board: CAREPLS's board of directors are considered experienced (9.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.2%.
Careplus Group Berhad's company bio, employee growth, exchange listings and data sources
- Name: Careplus Group Berhad
- Ticker: CAREPLS
- Exchange: KLSE
- Founded: 1988
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: RM960.615m
- Shares outstanding: 552.08m
- Website: https://www.careplus.com
Number of Employees
- Careplus Group Berhad
- Jalan Senawang 3
- Lot 120 & 121
- Negeri Sembilan
Careplus Group Berhad, an investment holding company, engages in the manufacture, processing, and trade of gloves in South America, North America, Europe, the Middle East, South Africa, Japan, China, Malay...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/07/30 17:50|
|End of Day Share Price||2021/07/30 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.